1 option
IL-2 in the immunotherapy of autoimmunity and cancer / Thomas Malek.
- Format:
- Video
- Author/Creator:
- Malek, Thomas, (University of Miami, USA), Speaker.
- Series:
- Henry Stewart talks. Biomedical & life sciences collection.
- The biomedical & life sciences collection, 2056-452X
- Language:
- English
- Subjects (All):
- Autoimmune diseases--Immunotherapy.
- Autoimmune diseases.
- Cancer--Immunotherapy.
- Cancer.
- Interleukin-2.
- Autoimmune Diseases--drug therapy.
- Immunotherapy--methods.
- Interleukin-2--therapeutic use.
- Mice.
- Neoplasms--drug therapy.
- Neoplasms--immunology.
- Receptors, Interleukin-2.
- T-Lymphocytes, Regulatory.
- Medical Subjects:
- Autoimmune Diseases--drug therapy.
- Immunotherapy--methods.
- Interleukin-2--therapeutic use.
- Mice.
- Neoplasms--drug therapy.
- Neoplasms--immunology.
- Receptors, Interleukin-2.
- T-Lymphocytes, Regulatory.
- Physical Description:
- 1 streaming video file (40 min.) : color, sound
- Place of Publication:
- London : Henry Stewart Talks, 2023.
- System Details:
- video file
- Contents:
- Contents: IL-2Rs
- IL-2 and regulatory T cells
- Therapy for autoimmune diseases
- Low-dose IL-2
- Clinical testing
- IL-2 for autoimmunity and cancer
- Mouse IL-2/CD25 fusion protein
- Key properties of IL-2/CD25
- IL-2 as a cancer immunotherapy
- IL-2-dependent anti-tumor immunity
- High-dose IL-2/CD25
- Clinical implications.
- Notes:
- Description based on publisher supplied metadata and other sources.
- Animated audio-visual presentation with synchronized narration.
- Title from title frames.
- Publisher Number:
- 6191 Henry Stewart Talks
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.